Pharmaceutical companies need to become more efficient in the way they develop drugs. We are looking for digital disruption of the whole value chain of drug development and saw a clear gap in translational medicine.

VeriSIM Life helps pharma predict clinical outcomes in a pre-clinical stage and reduce the amount of preclinical experimentation needed – meaning also fewer animal trials – and ultimately bringing better treatments to patients. Debiopharm wants to build a sustainable future for drug development and in VeriSIM Life we saw a company that shares our values.